Asset Search and BD AnalyticsCase Study
Asset search for business development opportunities for a company seeking to expand its rare disease portfolio, focused on central nervous system diseases
The Situation
- US-based pharmaceutical company, anticipating the launch of its new rare disease product, was seeking to add to its portfolio through licensing or acquisition opportunities
The Ask
- Client sought to uncover compelling opportunities, profile attractive assets, and determine which assets were worthy of further analysis
The Actions
Secondary Research
- Conducted extensive secondary research to build a database of asset opportunities, which were further prioritized by utilizing key product data, such as molecule’s mechanism of action, indications that were being pursued and the relevant preclinical and clinical data supporting development, insights into the treatment paradigm, unmet needs, and competitive landscape
- Reached out to asset holders to further vet select opportunities and assess business development actionability
The Impact
PROFILED high interest opportunities, including a company overview, disease and patient population background, product highlights (mechanism of action, clinical data, points of differentiation), and fit with the client’s criteria
PROVIDED ideas the client had not found and offered new ways to consider opportunities the client might have previously disregarded, as well as a methodology to compare those opportunities to ones already on the client’s radar
Representative Deliverables
Company Background
Asset Description
Clinical Data
Asset Profile
